首页 > 最新文献

Acta Haematologica Polonica最新文献

英文 中文
Characterization and prognostic factors of secondary to MDS/MPN and therapy-related AML: a single-center study MDS/MPN继发和治疗相关AML的特征和预后因素:一项单中心研究
Q3 Medicine Pub Date : 2023-05-06 DOI: 10.5603/ahp.a2023.0022
Piotr Strzałka, M. Czemerska, Kinga Krawiec, S. Szydłowska, D. Mikulski, A. Pluta, A. Wierzbowska
{"title":"Characterization and prognostic factors of secondary to MDS/MPN and therapy-related AML: a single-center study","authors":"Piotr Strzałka, M. Czemerska, Kinga Krawiec, S. Szydłowska, D. Mikulski, A. Pluta, A. Wierzbowska","doi":"10.5603/ahp.a2023.0022","DOIUrl":"https://doi.org/10.5603/ahp.a2023.0022","url":null,"abstract":"","PeriodicalId":35805,"journal":{"name":"Acta Haematologica Polonica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42478640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inspiration from Annual Meeting of European Society for Blood and Marrow Transplantation 来自欧洲血液和骨髓移植学会年会的启示
Q3 Medicine Pub Date : 2023-04-28 DOI: 10.5603/ahp.a2023.0021
J. Styczyński
{"title":"Inspiration from Annual Meeting of European Society for Blood and Marrow Transplantation","authors":"J. Styczyński","doi":"10.5603/ahp.a2023.0021","DOIUrl":"https://doi.org/10.5603/ahp.a2023.0021","url":null,"abstract":"","PeriodicalId":35805,"journal":{"name":"Acta Haematologica Polonica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49082110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Cell based-therapies in a patient with relapsing diffuse large B-cell lymphoma 复发性弥漫性大B细胞淋巴瘤的细胞治疗
Q3 Medicine Pub Date : 2023-04-28 DOI: 10.5603/ahp.a2023.2019
Agata Szymańska, M. Taszner, M. Dutka, J. Zaucha
{"title":"Cell based-therapies in a patient with relapsing diffuse large B-cell lymphoma","authors":"Agata Szymańska, M. Taszner, M. Dutka, J. Zaucha","doi":"10.5603/ahp.a2023.2019","DOIUrl":"https://doi.org/10.5603/ahp.a2023.2019","url":null,"abstract":"","PeriodicalId":35805,"journal":{"name":"Acta Haematologica Polonica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42898088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between tumor markers and anemia: a short review 肿瘤标志物与贫血的相关性综述
Q3 Medicine Pub Date : 2023-04-28 DOI: 10.5603/ahp.a2023.0014
Narjes Soltani, Bahareh Moghimian-Boroujeni, Mehrnaz Abdolalian, M. Javan
Tumor markers are a group of molecules used to diagnose certain diseases, including cancer. These molecules can alter cellular pathways, including those associated with some anemias, by expressing or influencing certain cellular mediators. The present study is based on data obtained from the PubMed database (1970–2019) using the key words ‘tumor markers’, ’anemia’ and ‘iron’. We found that some tumor markers can affect hepcidin expression and iron uptake by altering cell pathways. Several other tumor markers also increase in some anemias, so that they can sometimes be used to diagnose and confirm the type of anemia. The role of some tumor markers remains unclear de - spite the increase in some anemias. In general, some tumor markers are involved in the pathophysiology of a number of anemias or help diagnose anemia. However, studies of the role of tumor markers in the diagnosis, development or progression of anemias have been very limited.
肿瘤标志物是一组用于诊断某些疾病的分子,包括癌症。这些分子可以通过表达或影响某些细胞介质来改变细胞途径,包括与某些贫血相关的途径。本研究基于PubMed数据库(1970–2019)获得的数据,使用关键词“肿瘤标志物”、“贫血”和“铁”。我们发现一些肿瘤标志物可以通过改变细胞途径来影响铁调素的表达和铁摄取。其他一些肿瘤标志物在某些贫血中也会增加,因此它们有时可以用于诊断和确认贫血的类型。一些肿瘤标志物的作用仍然不清楚,尽管在一些贫血中有所增加。一般来说,一些肿瘤标志物参与了许多贫血的病理生理学或有助于诊断贫血。然而,关于肿瘤标志物在贫血的诊断、发展或进展中的作用的研究非常有限。
{"title":"Association between tumor markers and anemia: a short review","authors":"Narjes Soltani, Bahareh Moghimian-Boroujeni, Mehrnaz Abdolalian, M. Javan","doi":"10.5603/ahp.a2023.0014","DOIUrl":"https://doi.org/10.5603/ahp.a2023.0014","url":null,"abstract":"Tumor markers are a group of molecules used to diagnose certain diseases, including cancer. These molecules can alter cellular pathways, including those associated with some anemias, by expressing or influencing certain cellular mediators. The present study is based on data obtained from the PubMed database (1970–2019) using the key words ‘tumor markers’, ’anemia’ and ‘iron’. We found that some tumor markers can affect hepcidin expression and iron uptake by altering cell pathways. Several other tumor markers also increase in some anemias, so that they can sometimes be used to diagnose and confirm the type of anemia. The role of some tumor markers remains unclear de - spite the increase in some anemias. In general, some tumor markers are involved in the pathophysiology of a number of anemias or help diagnose anemia. However, studies of the role of tumor markers in the diagnosis, development or progression of anemias have been very limited.","PeriodicalId":35805,"journal":{"name":"Acta Haematologica Polonica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49475168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pneumatosis intestinalis after allogeneic hematopoietic cell transplantation 异基因造血细胞移植术后肠内气肿
Q3 Medicine Pub Date : 2023-04-09 DOI: 10.5603/ahp.a2023.0020
Tomasz Styczyński, Jagoda Sadlok, Z. Serafin, Monika Richert-Przygonska, R. Dębski, Krzysztof Czyżewski
{"title":"Pneumatosis intestinalis after allogeneic hematopoietic cell transplantation","authors":"Tomasz Styczyński, Jagoda Sadlok, Z. Serafin, Monika Richert-Przygonska, R. Dębski, Krzysztof Czyżewski","doi":"10.5603/ahp.a2023.0020","DOIUrl":"https://doi.org/10.5603/ahp.a2023.0020","url":null,"abstract":"","PeriodicalId":35805,"journal":{"name":"Acta Haematologica Polonica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49469668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tisagenlecleucel CAR-T for relapsed/refractory diffuse large B-cell lymphoma, one therapy; two different clinical presentations. An urgent need to design adverse event predictors 组织白细胞CAR-T治疗复发/难治性弥漫性大B细胞淋巴瘤,一种疗法;两种不同的临床表现。迫切需要设计不良事件预测因子
Q3 Medicine Pub Date : 2023-04-07 DOI: 10.5603/ahp.a2023.2018
Jaromir Tomasik, J. Drozd-Sokołowska, P. Kacprzyk, A. Tomaszewska, R. Machowicz, E. Urbanowska, Samanta Witkowska, G. Basak
{"title":"Tisagenlecleucel CAR-T for relapsed/refractory diffuse large B-cell lymphoma, one therapy; two different clinical presentations. An urgent need to design adverse event predictors","authors":"Jaromir Tomasik, J. Drozd-Sokołowska, P. Kacprzyk, A. Tomaszewska, R. Machowicz, E. Urbanowska, Samanta Witkowska, G. Basak","doi":"10.5603/ahp.a2023.2018","DOIUrl":"https://doi.org/10.5603/ahp.a2023.2018","url":null,"abstract":"","PeriodicalId":35805,"journal":{"name":"Acta Haematologica Polonica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43592269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of iron deficiency anemia on blood levels of interleukin 6 and infection rates in children: a pilot study 缺铁性贫血对儿童白细胞介素6水平和感染率的影响:一项初步研究
Q3 Medicine Pub Date : 2023-04-04 DOI: 10.5603/ahp.a2023.0017
A. Kolasa, G. Ręka, Zuzanna Radziejowska, A. Bielak, M. Janiszewska, K. Drabko
{"title":"Effect of iron deficiency anemia on blood levels of interleukin 6 and infection rates in children: a pilot study","authors":"A. Kolasa, G. Ręka, Zuzanna Radziejowska, A. Bielak, M. Janiszewska, K. Drabko","doi":"10.5603/ahp.a2023.0017","DOIUrl":"https://doi.org/10.5603/ahp.a2023.0017","url":null,"abstract":"","PeriodicalId":35805,"journal":{"name":"Acta Haematologica Polonica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46594282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SARS-CoV-2 infection in patients with multiple myeloma: survey in 23 centers across Europe and USA 多发性骨髓瘤患者的SARS-CoV-2感染:在欧洲和美国23个中心的调查
Q3 Medicine Pub Date : 2023-04-03 DOI: 10.5603/ahp.a2023.0016
D. Dytfeld, J. Radocha, R. Hájek, Guldane Cengiz-Seval, Meral Berkac, D. Coriu, B. Derman, A. Jakubowiak, V. Pečeliūnas, Gabor Mikkala, Ł. Bołkun, D. Hawrylecka, S. Grosicki, A. Tyczyńska, J. Zaucha, Wanda Knopińska, G. Semeńczuk, M. Morawska, K. Giannopoulos, A. Puła, M. Rymko, G. Charliński, A. Szeremet, E. Kalicińska, Lidia Usnarska, T. Wróbel, K. Jamroziak, A. Druzd-Sitek, Joanna Romejko Jarosińska, W. Sawicki, A. Waszczuk-Gajda, A. Juda, M. Hus, L. Gil
Introduction: Despite several studies, the impact of coronavirus disease 2019 on patients with multiple myeloma remains uncertain. Material(s) and Method(s): We performed a survey that covered the period of the first and second waves of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic in 23 centers inseven countries. Out of 352 patients with myeloma and SARS-CoV-2, 23% died. Results/Conclusions: Logistic regression showed a lower risk of death among patients treated with proteasome inhibitor and a higher risk of death for those who had a severe or a very severe course of disease.Copyright © 2023 Sciendo. All rights reserved.
引言:尽管进行了几项研究,但2019冠状病毒病对多发性骨髓瘤患者的影响仍不确定。材料和方法:我们在23个国家的中心进行了一项调查,涵盖了严重急性呼吸综合征冠状病毒2型(严重急性呼吸系统综合征冠状病毒冠状病毒2型)疫情的第一波和第二波。352名骨髓瘤和严重急性呼吸系统综合征冠状病毒2型患者中,23%死亡。结果/结论:Logistic回归显示,接受蛋白酶体抑制剂治疗的患者的死亡风险较低,而有严重或非常严重病程的患者的死亡率较高。版权所有©2023 Sciendo。保留所有权利。
{"title":"SARS-CoV-2 infection in patients with multiple myeloma: survey in 23 centers across Europe and USA","authors":"D. Dytfeld, J. Radocha, R. Hájek, Guldane Cengiz-Seval, Meral Berkac, D. Coriu, B. Derman, A. Jakubowiak, V. Pečeliūnas, Gabor Mikkala, Ł. Bołkun, D. Hawrylecka, S. Grosicki, A. Tyczyńska, J. Zaucha, Wanda Knopińska, G. Semeńczuk, M. Morawska, K. Giannopoulos, A. Puła, M. Rymko, G. Charliński, A. Szeremet, E. Kalicińska, Lidia Usnarska, T. Wróbel, K. Jamroziak, A. Druzd-Sitek, Joanna Romejko Jarosińska, W. Sawicki, A. Waszczuk-Gajda, A. Juda, M. Hus, L. Gil","doi":"10.5603/ahp.a2023.0016","DOIUrl":"https://doi.org/10.5603/ahp.a2023.0016","url":null,"abstract":"Introduction: Despite several studies, the impact of coronavirus disease 2019 on patients with multiple myeloma remains uncertain. Material(s) and Method(s): We performed a survey that covered the period of the first and second waves of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic in 23 centers inseven countries. Out of 352 patients with myeloma and SARS-CoV-2, 23% died. Results/Conclusions: Logistic regression showed a lower risk of death among patients treated with proteasome inhibitor and a higher risk of death for those who had a severe or a very severe course of disease.Copyright © 2023 Sciendo. All rights reserved.","PeriodicalId":35805,"journal":{"name":"Acta Haematologica Polonica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45460679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Zanubrutinib: a novel therapeutic option for the treatment of B-cell neoplasms Zanubrutinib:一种治疗B细胞肿瘤的新选择
Q3 Medicine Pub Date : 2023-04-02 DOI: 10.5603/ahp.a2023.0015
A. Majeranowski, Filip Lebiedziński, M. Okrój, Jakub Osowski, A. Mital
{"title":"Zanubrutinib: a novel therapeutic option for the treatment of B-cell neoplasms","authors":"A. Majeranowski, Filip Lebiedziński, M. Okrój, Jakub Osowski, A. Mital","doi":"10.5603/ahp.a2023.0015","DOIUrl":"https://doi.org/10.5603/ahp.a2023.0015","url":null,"abstract":"","PeriodicalId":35805,"journal":{"name":"Acta Haematologica Polonica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44114218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibiotic prophylaxis: a chance to reduce infections during childhood leukemia treatment 抗生素预防:减少儿童白血病治疗期间感染的机会
Q3 Medicine Pub Date : 2023-03-24 DOI: 10.5603/ahp.a2023.0012
Natalia Zaj, Wojciech Makuch, M. Lejman, Joanna Zawitkowska
{"title":"Antibiotic prophylaxis: a chance to reduce infections during childhood leukemia treatment","authors":"Natalia Zaj, Wojciech Makuch, M. Lejman, Joanna Zawitkowska","doi":"10.5603/ahp.a2023.0012","DOIUrl":"https://doi.org/10.5603/ahp.a2023.0012","url":null,"abstract":"","PeriodicalId":35805,"journal":{"name":"Acta Haematologica Polonica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41895107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta Haematologica Polonica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1